Axcella Health (AXLA) Gets a Hold From H.C. Wainwright
TipRanksMay 8, 2023 06:36 ET
H.C. Wainwright Keeps Their Hold Rating on Axcella Health (AXLA)
TipRanksApr 3, 2023 06:26 ET
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
TipRanksMar 31, 2023 08:22 ET
Axcella Health (AXLA) Gets a Hold From H.C. Wainwright
TipRanksFeb 16, 2023 15:30 ET
Axcella Health Analyst Ratings
Benzinga Analyst RatingsFeb 16, 2023 11:57 ET
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
TipRanksFeb 16, 2023 08:30 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Axcella Health (AXLA) and Baudax Bio (BXRX)
TipRanksJan 25, 2023 08:15 ET
H.C. Wainwright Reaffirms Their Hold Rating on Axcella Health (AXLA)
TipRanksJan 24, 2023 06:30 ET
Axcella Health Analyst Ratings
Benzinga Analyst RatingsDec 16, 2022 06:27 ET
SVB Leerink Downgrades Axcella Health to Market Perform, Lowers Price Target to $2
Benzinga Real-time NewsDec 16, 2022 06:27 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: ATyr Pharma (LIFE) and Axcella Health (AXLA)
TipRanksDec 15, 2022 14:10 ET
Axcella Health Analyst Ratings
Benzinga Analyst RatingsDec 15, 2022 14:07 ET
SVB Securities Keeps Their Buy Rating on Axcella Health (AXLA)
TipRanksNov 4, 2022 01:15 ET
Chardan Capital Maintains Buy on Axcella Health, Lowers Price Target to $5
Benzinga Real-time NewsNov 2, 2022 10:36 ET
Axcella Health Analyst Ratings
Benzinga Analyst RatingsNov 2, 2022 10:34 ET
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
TipRanksNov 2, 2022 08:15 ET
Analysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Axcella Health (AXLA)
TipRanksNov 2, 2022 07:00 ET
Wedbush Adjusts Axcella Health's Price Target to $6 From $9, Citing Stock Dilution; Outperform Rating Kept
MT NewswiresOct 14, 2022 06:42 ET
Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
Benzinga Real-time NewsOct 3, 2022 07:16 ET
HC Wainwright Adjusts Axcella Health's Price Target to $10 From $8, Maintains Buy Rating
MT NewswiresOct 3, 2022 06:50 ET
No Data
No Data